Renexxion Ireland Ltd. Announces Issuance of Sixth New U.S. Patent Covering New Naronapride Trihydrate Formulation, Dosage Forms, and Treatment of GI Disorders

ROSCREA, Ireland, Jan. 08, 2026 (GLOBE NEWSWIRE) — Renexxion Ireland Limited (“Renexxion”), a private biopharmaceutical company focused on advancing new therapies for patients with significant unmet needs in gastrointestinal (“GI”) disorders, announced that the United States Patent and Trademark Office (“USPTO”) has granted its sixth U.S. patent for naronapride. The patent (Patent No. 12,391,684) encompasses […]

Allegro MicroSystems to Announce Third Quarter Fiscal Year 2026 Financial Results

(NASDAQ:ALGM), MANCHESTER, N.H., Jan. 08, 2026 (GLOBE NEWSWIRE) — Allegro MicroSystems, Inc. (Nasdaq: ALGM) today announced it plans to release financial results for its third quarter fiscal year 2026 prior to the market open on Thursday, January 29, 2026. Following the press release, Mike Doogue, President and Chief Executive Officer, and Derek D'Antilio, Executive Vice

StoneX Announces Strategic Partnership with Enhanced Digital Group and Leads Series A Funding Round

StoneX Announces Strategic Partnership with Enhanced Digital Group and Leads Series A Funding Round GlobeNewswire January 08, 2026 NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) — StoneX Group Inc. (“StoneX”; NASDAQ: SNEX) and Enhanced Digital Group Inc. (“EDG”) announced today that StoneX Digital, a division of StoneX, and EDG have entered into a strategic partnership

InflaRx Announces Strategy Focused on Capital-Efficient Execution with Izicopan and Near-Term Value Creation

InflaRx Announces Strategy Focused on Capital-Efficient Execution with Izicopan and Near-Term Value Creation GlobeNewswire January 08, 2026 InflaRx to prioritize izicopan as its leading pipeline asset, with a goal of continuing toward Phase 2b readiness in hidradenitis suppurativa (HS) To broaden signal-finding activities for izicopan in additional I&I (inflammation and immunology) indications, InflaRx intends to

Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa

Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa GlobeNewswire January 08, 2026 GAITHERSBURG, Md. and PARIS and ADDIS ABABA, Ethiopia, Jan. 08, 2026 (GLOBE NEWSWIRE) — Today Emergent BioSolutions (NYSE: EBS) announced a collaboration agreement with PANTHER to provide additional financial support to continue progressing

Texxon Holding Limited Completes Key Safety and Regulatory Milestones for 600,000-Ton Polystyrene Project

Texxon Holding Limited Completes Key Safety and Regulatory Milestones for 600,000-Ton Polystyrene Project GlobeNewswire January 08, 2026 SHANGHAI, China, Jan. 08, 2026 (GLOBE NEWSWIRE) — Texxon Holding Limited (Nasdaq: NPT) (the “Company” or “Texxon”), a leading provider of supply chain management services in the plastics and chemical industries in East China, today announced the successful

Alps Group Inc Appoints Cheing Lye-Ping as Chief Financial Officer

Alps Group Inc Appoints Cheing Lye-Ping as Chief Financial Officer GlobeNewswire January 08, 2026 KUALA LUMPUR, Malaysia, Jan. 08, 2026 (GLOBE NEWSWIRE) — Alps Group Inc (NASDAQ: ALPS) (the “Company” or “Alps Group”), a fully integrated biotechnology research and healthcare platform specializing in predictive, preventive, and precision medicine, today announced the appointment of Cheing Lye-Ping

LiveOne (NASDAQ: LVO) Achieves Major Milestones, Closes $65M+ in Partnership Revenue

LiveOne (NASDAQ: LVO) Achieves Major Milestones, Closes $65M+ in Partnership Revenue GlobeNewswire January 08, 2026 B2B partners span carriers, retail, consumer electronics, entertainment, automotive and hospitality Identified $4-5 million in incremental cost savings through expanded AI initiatives Surpasses 1.4 million total members and ad-supported subscribers, including Tesla customers Record B2B pipeline with 100+ partnerships LOS

Silicon Valley Acquisition Corp. Announces Closing of Over-Allotment Option in Connection with Its Initial Public Offering

Silicon Valley Acquisition Corp. Announces Closing of Over-Allotment Option in Connection with Its Initial Public Offering GlobeNewswire January 08, 2026 PALO ALTO, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) — Silicon Valley Acquisition Corp. (the “Company”) (Nasdaq: SVAQU) today announced that, on January 7, 2026, it consummated the sale of 1,500,000 units subject to the over-allotment

IP Strategy Publishes Monthly Validator & Ecosystem Update

IP Strategy Publishes Monthly Validator & Ecosystem Update Monthly release covers the period from December 1-31, 2025 GlobeNewswire January 08, 2026 GIG HARBOR, Wash., Jan. 08, 2026 (GLOBE NEWSWIRE) — IP Strategy (Nasdaq: IPST) (the “Company”), the first company to adopt a treasury reserve policy centered on the $IP token, releases its monthly publication detailing

Scroll to Top